webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-L-Tyr(PEG(3)-N3)-OH

  CAS No.: 1831059-64-3   Cat No.: BADC-01849 4.5  

Boc-L-Tyr(PEG(3)-N3)-OH is an azide-functionalized ADC linker intermediate with a PEG3 spacer, enabling efficient copper-free click chemistry for site-specific antibody conjugation, enhancing antibody-drug conjugate stability and targeted drug delivery.

Boc-L-Tyr(PEG(3)-N3)-OH

Structure of 1831059-64-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C20H30N4O7
Molecular Weight
438.47

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(2S)-3-[4-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
Canonical SMILES
CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)OCCOCCOCCN=[N+]=[N-])C(=O)O
InChI
InChI=1S/C20H30N4O7/c1-20(2,3)31-19(27)23-17(18(25)26)14-15-4-6-16(7-5-15)30-13-12-29-11-10-28-9-8-22-24-21/h4-7,17H,8-14H2,1-3H3,(H,23,27)(H,25,26)/t17-/m0/s1
InChIKey
AUSAOIRHJVEPQZ-KRWDZBQOSA-N

Boc-L-Tyr(PEG(3)-N3)-OH is a chemical compound used in the development of advanced biomedical and biochemical applications. Here are some key applications of Boc-L-Tyr(PEG(3)-N3)-OH:

Biomedical Research: Boc-L-Tyr(PEG(3)-N3)-OH is utilized in the development of drug delivery systems, where its PEG moiety imparts increased solubility and biocompatibility. This compound can be conjugated to therapeutic agents, enhancing their targeted delivery to specific tissues or cells. Researchers often employ it in designing new treatments for cancers and chronic diseases.

Protein Engineering: In protein engineering, Boc-L-Tyr(PEG(3)-N3)-OH is used for site-specific modifications of proteins and peptides. The azide group allows for selective conjugation via click chemistry, enabling the attachment of various functional groups or probes. This facilitates the development of protein-based therapeutics and diagnostics with enhanced properties.

Immunoassays: Boc-L-Tyr(PEG(3)-N3)-OH is valuable in the creation of highly specific and sensitive immunoassays. Its PEG linker can help reduce nonspecific binding and increase the stability of assay components. By conjugating this compound to antibodies or antigens, more accurate and reliable diagnostic tests can be developed.

Surface Modification: Boc-L-Tyr(PEG(3)-N3)-OH is used in surface modification of biomaterials to improve biocompatibility and functionality. The PEG segment provides a hydrophilic layer that reduces protein adsorption and cell adhesion, making it ideal for medical implants and devices. This modification enhances the longevity and performance of medical implants.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 1-BOC-Azetidine-3-carboxylic acid methyl ester | Mc-Gly-Gly-Phe-Gly-PAB-OH TFA | H-L-Lys(N3-Gly)-OH hydrochloride | trans-Cyclooctene-PEG(3)-maleimide | H-L-Lys(4-N3-Z)-OH HCl | MC-Gly-Gly-D-Phe | Boc-L-Tyr(PEG(3)-N3)-OH
Send Inquiry
Verification code
Inquiry Basket